| From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma V Ratushny, MD Gober, R Hick, TW Ridky, JT Seykora The Journal of clinical investigation 122 (2), 464-472, 2012 | 634 | 2012 |
| Synthetic lethal screen of an EGFR-centered network to improve targeted therapies I Astsaturov, V Ratushny, A Sukhanova, MB Einarson, T Bagnyukova, ... Science signaling 3 (140), ra67-ra67, 2010 | 155 | 2010 |
| Targeting EGFR resistance networks in head and neck cancer V Ratushny, I Astsaturov, BA Burtness, EA Golemis, JS Silverman Cellular signalling 21 (8), 1255-1268, 2009 | 117 | 2009 |
| Mechanisms of tumor resistance to EGFR-targeted therapies EA Hopper-Borge, RE Nasto, V Ratushny, LM Weiner, EA Golemis, ... Expert opinion on therapeutic targets 13 (3), 339-362, 2009 | 109 | 2009 |
| Resolving the network of cell signaling pathways using the evolving yeast two-hybrid system V Ratushny, EA Golemis Biotechniques 44 (5), 655-662, 2008 | 52 | 2008 |
| Extracellular 70-kd heat shock protein in mid-trimester amniotic fluid and its effect on cytokine production by ex vivo–cultured amniotic fluid cells C Jean-Pierre, SC Perni, AM Bongiovanni, RB Kalish, E Karasahan, ... American journal of obstetrics and gynecology 194 (3), 694-698, 2006 | 41 | 2006 |
| Case of moyamoya disease in a patient with advanced acquired immunodeficiency syndrome SR Sharfstein, S Ahmed, MQ Islam, MI Najjar, V Ratushny Journal of Stroke and Cerebrovascular Diseases 16 (6), 268-272, 2007 | 35 | 2007 |
| Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death V Ratushny, HB Pathak, N Beeharry, N Tikhmyanova, F Xiao, T Li, ... Oncogene 31 (10), 1217-1227, 2012 | 32 | 2012 |
| Differential expression of immune system–related components in midtrimester amniotic fluid from singleton and twin pregnancies SC Perni, RB Kalish, JM Hutson, E Karasahin, AM Bongiovanni, ... American journal of obstetrics and gynecology 193 (3), 942-946, 2005 | 19 | 2005 |
| The effect of medical malpractice on dermatology and related specialties V Ratushny, HB Allen J Med Sci Res 1, 16, 2007 | 10 | 2007 |
| COMBINATION THERAPY FOR THE TREATMENT OF CANCER V RATUSHNY WO Patent WO/2009/114,703, 2009 | 6 | 2009 |
| A Symmetric Eczematous Eruption Harboring Thousands of Melanocytic Lesions. TH Ratushny V, Kraft S, Moschella SL, Duncan LM, Lawrence DP JAMA Dermatology 152 (9), 1021-1024, 2016 | 1 | 2016 |
| COMBINATION THERAPY BASED ON SRC AND AURORA KINASE INHIBITION FOR THE TREATMENT OF CANCER V RATUSHNY, EA GOLEMIS, IG SEREBRIISKII, LM WEINER, ... WO Patent WO/2010/068,951, 2010 | 1* | 2010 |
| The children of physicians V Ratushny Pharos, 27, 2012 | | 2012 |
| The Interplay of Aurora Kinase A, EGFR, and SRC Pathways in Regulating Cancer Resistance to Targeted Therapy V Ratushny Drexel University, College of Medicine, Molecular and Cell Biology and …, 2011 | | 2011 |
| Srcasm biology-a potential link between Notch 1 and senescence L Zhao, X Yang, V Ratushny, C Marshall, T Dentchev, W Pear, J Seykora JOURNAL OF INVESTIGATIVE DERMATOLOGY 130, S30-S30, 2010 | | 2010 |
| High throughput image analysis to enhance an siRNA-based screen for genes conferring resistance to EGFR-targeting drugs. V Paralkar, I Serebriiskii, I Astsaturov, M Einarson, V Ratushny, Y Zhou, ... Cancer Research 68 (9_Supplement), 919-919, 2008 | | 2008 |
